Skip to main content
Top
Published in: BMC Clinical Pathology 1/2016

Open Access 01-12-2016 | Research article

Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7–9 year old Zimbabwean children: a cross sectional study

Authors: Grace Mashavave, Patience Kuona, Willard Tinago, Babill Stray-Pedersen, Marshall Munjoma, Cuthbert Musarurwa

Published in: BMC Clinical Pathology | Issue 1/2016

Login to get access

Abstract

Background

Omega-3 long chain-polyunsaturated fatty acids (LC-PUFAs)–docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA)– and omega-6 LC-PUFA arachidonic acid (ARA), are essential for optimum physical and mental development in children. Prior to this study, the blood omega-3 LC-PUFA levels were unknown in Zimbabwean children, particularly in those aged 7–9 years, despite the documented benefits of LC-PUFAs. Documentation of the LC-PUFA levels in this age group would help determine whether interventions, such as fortification, are necessary. This study aimed to determine dried whole blood spot omega-3 and omega-6 LC-PUFA levels and LC-PUFA reference intervals among a selected group of Zimbabwean children aged 7–9 years old.

Methods

We conducted a cross sectional study from September 2011 to August 2012 on a cohort of peri-urban, Zimbabwean children aged 7–9 years. The children were born to mothers enrolled at late pregnancy into an HIV prevention program between 2002 and 2004. Dried whole blood spots were sampled on butylated hydroxytoluene antioxidant impregnated filter papers and dried. LC-PUFAs were quantified using gas liquid chromatography. Differences in LC-PUFAs between groups were compared using the Kruskal Wallis test and reference intervals determined using non-parametric statistical methods.

Results

LC-PUFAs levels were determined in 297 Zimbabwean children of whom 170 (57.2 %) were girls. The study determined that LC-PUFAs (wt/wt) ranges were EPA 0.06–0.55 %, DPA 0.38–1.98 %, DHA 1.13–3.52 %, ARA 5.58–14.64 % and ARA: EPA ratio 15.47–1633.33. Sixteen participants had omega-3 LC-PUFAs levels below the determined reference intervals, while 18 had higher omega-6 LC-PUFAs. The study did not show gender differences in omega-3 and omega-6 LC-PUFAs levels (all p > 0.05). EPA was significantly higher in the 8 year age group compared to those aged 7 and 9 years (median; 0.20 vs 0.17 vs 0.18, respectively, p = 0.049). ARA: EPA ratio was significantly higher in the 7 year age group compared to those aged 8 and 9 years (median; 64.38 vs 56.43 vs 55.87 respectively, p = 0.014).

Conclusions

In this cohort of children, lower EPA levels and higher ARA: EPA ratios were observed compared to those reported in apparently healthy children elsewhere. The high ARA: EPA ratios might increase the vulnerability of these children to inflammatory pathologies. Identification and incorporation into diet of locally produced foodstuffs rich in omega-3 LC-PUFAs is recommended as well as advocating for dietary supplementation with omega-3 fish oils and algae based oils.
Literature
1.
go back to reference Mozurkewich E, Berman DR, Chilmigras J. Role of Omega-3 Fatty Acids in Maternal, Fetal, Infant and Child Wellbeing. Expert Rev Obstet Gynecol. 2010;5(1):125–38.CrossRef Mozurkewich E, Berman DR, Chilmigras J. Role of Omega-3 Fatty Acids in Maternal, Fetal, Infant and Child Wellbeing. Expert Rev Obstet Gynecol. 2010;5(1):125–38.CrossRef
2.
go back to reference Schuchardt JP, Huss M, Stauss-Garbo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr. 2010;169(2):149–64.CrossRefPubMed Schuchardt JP, Huss M, Stauss-Garbo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr. 2010;169(2):149–64.CrossRefPubMed
3.
go back to reference Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF and Montgomery P. Docosahexaenoic Acid for Reading, Cognition and behavior in Children Aged 7-9 Years: A Randomized, Control Trial (the DOLAB Study). PLoS ONE 2012;7(9):e43909. doi: 10.1371. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF and Montgomery P. Docosahexaenoic Acid for Reading, Cognition and behavior in Children Aged 7-9 Years: A Randomized, Control Trial (the DOLAB Study). PLoS ONE 2012;7(9):e43909. doi: 10.1371.
4.
go back to reference Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1:420–39.CrossRefPubMed Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1:420–39.CrossRefPubMed
5.
go back to reference Bailey N. Immunonutrition: the role of long chain omega-3 fatty acids. The Nutrition Practitioner Spring 2010;11(1):24-26. Bailey N. Immunonutrition: the role of long chain omega-3 fatty acids. The Nutrition Practitioner Spring 2010;11(1):24-26.
6.
go back to reference Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids. J Nutr Metab. 2012. doi:10.1155/2012/539426. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids. J Nutr Metab. 2012. doi:10.​1155/​2012/​539426.
7.
go back to reference Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372–87.CrossRefPubMed Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372–87.CrossRefPubMed
8.
go back to reference Gunveen K, Cameron-Smith D, Garg M, Sinclair AJ. Docosapentaenoic acid (22:5n-3): A review of its biological effects. Prog Lipid Res. 2011;50:28–34.CrossRef Gunveen K, Cameron-Smith D, Garg M, Sinclair AJ. Docosapentaenoic acid (22:5n-3): A review of its biological effects. Prog Lipid Res. 2011;50:28–34.CrossRef
9.
go back to reference Kidd PM. Omega-3 DHA and EPA for Cognition, Behaviour, and Mood: Functional Synergies with Cell Membrane, Phospholipids. Altern Med Rev. 2007;12(3):207–27.PubMed Kidd PM. Omega-3 DHA and EPA for Cognition, Behaviour, and Mood: Functional Synergies with Cell Membrane, Phospholipids. Altern Med Rev. 2007;12(3):207–27.PubMed
10.
go back to reference Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids. 2013;88:201–10.CrossRefPubMed Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids. 2013;88:201–10.CrossRefPubMed
11.
go back to reference Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, et al. Docosahexaenoic acid restores endothelial function in children with hyperlipemia: results from the EARLY Study. Int J Clin Pharmacol Ther. 2004;42(12):672–9.CrossRefPubMed Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, et al. Docosahexaenoic acid restores endothelial function in children with hyperlipemia: results from the EARLY Study. Int J Clin Pharmacol Ther. 2004;42(12):672–9.CrossRefPubMed
12.
go back to reference Norris JM, Yin X, Lamb MM, Barriga K, Sifert J, Hoffman M, et al. Omega-3 Polyunsaturated Fatty Acid intake and Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes. J Am Med Assoc. 2007;298(12):1420–8.CrossRef Norris JM, Yin X, Lamb MM, Barriga K, Sifert J, Hoffman M, et al. Omega-3 Polyunsaturated Fatty Acid intake and Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes. J Am Med Assoc. 2007;298(12):1420–8.CrossRef
13.
go back to reference Forsyth JS, Willatts P, Agostoni C, Bissenden J, Casaer P, Boehm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomized controlled trial. Br Med J. 2003;953-doi:10.1136/bmj.326.7396.953-955. Forsyth JS, Willatts P, Agostoni C, Bissenden J, Casaer P, Boehm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomized controlled trial. Br Med J. 2003;953-doi:10.​1136/​bmj.​326.​7396.​953-955.
14.
go back to reference Daak AA, Ghebremeskel K, Hassan Z, Attallah B, Azan B, Elbashir MI, Crawford M. Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2013;97:37–44.CrossRefPubMed Daak AA, Ghebremeskel K, Hassan Z, Attallah B, Azan B, Elbashir MI, Crawford M. Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2013;97:37–44.CrossRefPubMed
15.
go back to reference Vilaseca MA, Gomez-Lopez L, Lambruschini N, Gutiérrez A, García R, Meavilla S, et al. Long-chain polyunsaturated fatty acid concentration in patients with inborn errors of metabolism. Nutr Hosp 2011;26(1):128–136. Vilaseca MA, Gomez-Lopez L, Lambruschini N, Gutiérrez A, García R, Meavilla S, et al. Long-chain polyunsaturated fatty acid concentration in patients with inborn errors of metabolism. Nutr Hosp 2011;26(1):128–136.
16.
go back to reference Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of Fish Oil Supplementation of Fatty Acid Status, Coordination and Fine Motor Skills in Children with Phenylketonuria. J Pediatr. 2007;150:479–84.CrossRefPubMed Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of Fish Oil Supplementation of Fatty Acid Status, Coordination and Fine Motor Skills in Children with Phenylketonuria. J Pediatr. 2007;150:479–84.CrossRefPubMed
17.
go back to reference Janczyk W, Socha P, Lebenesztein D, Wierzbicka A, Mazur A, Neuhoff-Murawska J, Matusik P. Omega-3 fatty acids treatment of non-alcoholic fatty liver disease: design and rationale of randomised controlled trial. BMC Pediatr. 2013;13:85.CrossRefPubMedPubMedCentral Janczyk W, Socha P, Lebenesztein D, Wierzbicka A, Mazur A, Neuhoff-Murawska J, Matusik P. Omega-3 fatty acids treatment of non-alcoholic fatty liver disease: design and rationale of randomised controlled trial. BMC Pediatr. 2013;13:85.CrossRefPubMedPubMedCentral
18.
go back to reference Nobili V, Alisi A, Corte CD, Risé P, Galli C, Agostoni C, Bedogni G. Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis. 2013;23(11):1066–70.CrossRefPubMed Nobili V, Alisi A, Corte CD, Risé P, Galli C, Agostoni C, Bedogni G. Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis. 2013;23(11):1066–70.CrossRefPubMed
19.
go back to reference Belanger SA, Vanasse M, Spahis S, Sylvester MP, Lippe S, L’heureux F, Ghadirian P, Vanasse CM, Levy E. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009;14:89–98.PubMedPubMedCentral Belanger SA, Vanasse M, Spahis S, Sylvester MP, Lippe S, L’heureux F, Ghadirian P, Vanasse CM, Levy E. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009;14:89–98.PubMedPubMedCentral
20.
go back to reference Bell JG, Miller D, MacDonald DJ, MacKinlay EE, Dick JR, Cheseldine S, et al. The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake. Br J Nutr. 2010;103:1160–7.PubMed Bell JG, Miller D, MacDonald DJ, MacKinlay EE, Dick JR, Cheseldine S, et al. The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake. Br J Nutr. 2010;103:1160–7.PubMed
21.
go back to reference Biltagi MA, Baset AA, Bassiouny M, Attia M. Omega-3 fatty acids, vitamin C, and Zn supplementation in asthmatic children: A randomized self-controlled study. Acta Paediatr. 2009;98:737–42.CrossRefPubMed Biltagi MA, Baset AA, Bassiouny M, Attia M. Omega-3 fatty acids, vitamin C, and Zn supplementation in asthmatic children: A randomized self-controlled study. Acta Paediatr. 2009;98:737–42.CrossRefPubMed
22.
go back to reference Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Snayal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline but the American Association for the liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.CrossRefPubMed Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Snayal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline but the American Association for the liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.CrossRefPubMed
23.
go back to reference Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J. 1998;11:361–5.CrossRefPubMed Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J. 1998;11:361–5.CrossRefPubMed
24.
go back to reference Miller MR, Yin X, Seifert J, Clare-Salzler M, Eisenbarth GS, Rewers M, Norris JM. Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Paediatr Diabetes. 2011;12:669–75.CrossRef Miller MR, Yin X, Seifert J, Clare-Salzler M, Eisenbarth GS, Rewers M, Norris JM. Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Paediatr Diabetes. 2011;12:669–75.CrossRef
25.
go back to reference Mankad DA, Dupuis A, Smile S, Roberts W, Brian J, Lui T, Genore L, Zaghloul D, Iaboni A, Marcon PMA, Anagnostou E. A randomized, placebo controlled trial og omega-3 fatty acids in the treatment of young children with autism. Molecular Autism. 2015;6(18). doi:10.1186/s13229-015-0010-7. Mankad DA, Dupuis A, Smile S, Roberts W, Brian J, Lui T, Genore L, Zaghloul D, Iaboni A, Marcon PMA, Anagnostou E. A randomized, placebo controlled trial og omega-3 fatty acids in the treatment of young children with autism. Molecular Autism. 2015;6(18). doi:10.​1186/​s13229-015-0010-7.
26.
go back to reference Gibson RA, Muhlhausler B, Makrides M. Conversion of Linolenic acid and alpha-linolenic acid to long chain polyunsaturated fatty acids, with focus on pregnancy, lactation and the first 2 years of life. Matern Child Nutr. 2011;Suppl 2:17–26.CrossRef Gibson RA, Muhlhausler B, Makrides M. Conversion of Linolenic acid and alpha-linolenic acid to long chain polyunsaturated fatty acids, with focus on pregnancy, lactation and the first 2 years of life. Matern Child Nutr. 2011;Suppl 2:17–26.CrossRef
27.
go back to reference Glaser C, Lattka E, Rzehak P, Steer C, Koletzko B. Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr. 2011;7 Suppl 2:27–40.CrossRefPubMed Glaser C, Lattka E, Rzehak P, Steer C, Koletzko B. Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr. 2011;7 Suppl 2:27–40.CrossRefPubMed
28.
go back to reference Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–79.CrossRefPubMed Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–79.CrossRefPubMed
29.
go back to reference Decsi T, Kennedy K. Sex-specific differences in essential fatty acids metabolism. Am J Clin Nutr. 2011;94(Suppl):1914s–1919S. Decsi T, Kennedy K. Sex-specific differences in essential fatty acids metabolism. Am J Clin Nutr. 2011;94(Suppl):1914s–1919S.
30.
go back to reference Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopment disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia, and the autism spectrum. Prostaglandins Leukot Essent Fatty Acids. 2000;63:1–9.CrossRefPubMed Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopment disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia, and the autism spectrum. Prostaglandins Leukot Essent Fatty Acids. 2000;63:1–9.CrossRefPubMed
31.
go back to reference Das UN. A defect in Delta6 and Delta5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians. Lipids Health Dis. 2010;9:130.CrossRefPubMedPubMedCentral Das UN. A defect in Delta6 and Delta5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians. Lipids Health Dis. 2010;9:130.CrossRefPubMedPubMedCentral
32.
go back to reference Infante JP, Huszagh VA. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of disease of oxidative phosphorylation and beta-oxidation. FEBS Lett. 2000;468:1–5.CrossRefPubMed Infante JP, Huszagh VA. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of disease of oxidative phosphorylation and beta-oxidation. FEBS Lett. 2000;468:1–5.CrossRefPubMed
33.
go back to reference Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts CM. A randomised control trial in school children showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fat Acids. 2009;80:143–9.CrossRef Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts CM. A randomised control trial in school children showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fat Acids. 2009;80:143–9.CrossRef
34.
go back to reference Tichelaar HY, Smuts CM, Kvalsvig JD, et al. Randomised study of cognitive effects of omega-3 fatty acid supplementation in undernourished rural school children. S Afr J Clin Nutr. 2000;13:100. abstr. Tichelaar HY, Smuts CM, Kvalsvig JD, et al. Randomised study of cognitive effects of omega-3 fatty acid supplementation in undernourished rural school children. S Afr J Clin Nutr. 2000;13:100. abstr.
35.
go back to reference Baumgartner J, Smuts CM, Malan L, Kvalsvig J, van Stuijvenberg ME, Hurrell RF, Zimmermann MB. Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: A Randomized double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr. 2012;96(6):1327-38. doi: 10.3945/ajcn.112.041004. Baumgartner J, Smuts CM, Malan L, Kvalsvig J, van Stuijvenberg ME, Hurrell RF, Zimmermann MB. Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: A Randomized double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr. 2012;96(6):1327-38. doi: 10.​3945/​ajcn.​112.​041004.
36.
go back to reference Mahomed K, Williams MA, King IB, Mudzamiri S, Woelk GB. Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res. 2007;56(1):37–50.PubMed Mahomed K, Williams MA, King IB, Mudzamiri S, Woelk GB. Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res. 2007;56(1):37–50.PubMed
37.
go back to reference Bailey-Hall E, Nelson EB, Ryan AS. Validation of a rapid measure of blood PUFA levels in humans. Lipids. 2008;43(2):181–6.CrossRefPubMed Bailey-Hall E, Nelson EB, Ryan AS. Validation of a rapid measure of blood PUFA levels in humans. Lipids. 2008;43(2):181–6.CrossRefPubMed
38.
go back to reference Ichihara K, Waku K, Yamaguchi C, Saito K, Shibahara A, Miyatani S, Yamamoto K: A convenient method for determination of the C 20-22 PUFA composition of glycerolipids in blood and breast milk. Lipids 2002;37(5):523–6 Ichihara K, Waku K, Yamaguchi C, Saito K, Shibahara A, Miyatani S, Yamamoto K: A convenient method for determination of the C 20-22 PUFA composition of glycerolipids in blood and breast milk. Lipids 2002;37(5):523–6
39.
go back to reference Bell JG, Mackinlay EE, Dick JR, Younger I, Lands B, Gilhooly T. Using a fingertip whole blood sample for rapid fatty acid measurement: method validation and correlation with erythrocyte polar lipid compositions in UK subjects. Br J Nutr. 2011;106:1408–15.CrossRefPubMed Bell JG, Mackinlay EE, Dick JR, Younger I, Lands B, Gilhooly T. Using a fingertip whole blood sample for rapid fatty acid measurement: method validation and correlation with erythrocyte polar lipid compositions in UK subjects. Br J Nutr. 2011;106:1408–15.CrossRefPubMed
40.
go back to reference Marangoni F, Colombo C, Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem. 2004;326:267–72.CrossRefPubMed Marangoni F, Colombo C, Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem. 2004;326:267–72.CrossRefPubMed
41.
go back to reference Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol. 2006;17(1):22–7.CrossRefPubMed Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol. 2006;17(1):22–7.CrossRefPubMed
42.
go back to reference Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study. PLoS One. 2013;8(6):e66697.CrossRefPubMedPubMedCentral Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study. PLoS One. 2013;8(6):e66697.CrossRefPubMedPubMedCentral
43.
go back to reference Taborda-Barats L, Potter PC. Socio-epidemiological Aspects of Respiratory Allergic Diseases in Southern Africa. World Allergy Organization J. 2012;5:1–8.CrossRef Taborda-Barats L, Potter PC. Socio-epidemiological Aspects of Respiratory Allergic Diseases in Southern Africa. World Allergy Organization J. 2012;5:1–8.CrossRef
44.
go back to reference Thatcher RW. Maturation of the human frontal lobes. Physiological evidence for staging. Dev Neuropsychol. 1991;1:397–419.CrossRef Thatcher RW. Maturation of the human frontal lobes. Physiological evidence for staging. Dev Neuropsychol. 1991;1:397–419.CrossRef
45.
go back to reference Glaser C, Demmelmair H, Sausenthaler S, Herbarth O, Heinrich J, Koletzko B. Fatty acid composition serum glycophospholipids in children. J Pediatr. 2010;157:826–31.CrossRefPubMed Glaser C, Demmelmair H, Sausenthaler S, Herbarth O, Heinrich J, Koletzko B. Fatty acid composition serum glycophospholipids in children. J Pediatr. 2010;157:826–31.CrossRefPubMed
46.
go back to reference Wolters MSH, Foraita R, Galli C, Risé P, Moreni LA, Molnár D, Russo P, Veidebaum T, Tornaritis M, Vyncke K, Eiben G, Lacoviello L, Ahrens W. Reference values of whole-blood fatty acids by age and sex from European children aged 3–8 years. Int J Obes. 2014;38:S86–98.CrossRef Wolters MSH, Foraita R, Galli C, Risé P, Moreni LA, Molnár D, Russo P, Veidebaum T, Tornaritis M, Vyncke K, Eiben G, Lacoviello L, Ahrens W. Reference values of whole-blood fatty acids by age and sex from European children aged 3–8 years. Int J Obes. 2014;38:S86–98.CrossRef
47.
go back to reference Kurewa NE, Munjoma MW, Chirenje ZM, Rusakaniko S, Hussain A, Stray-Pedersen B. Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe. Cent Afr J Med. 2007;53(5–8):25–30.PubMed Kurewa NE, Munjoma MW, Chirenje ZM, Rusakaniko S, Hussain A, Stray-Pedersen B. Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe. Cent Afr J Med. 2007;53(5–8):25–30.PubMed
48.
go back to reference Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–20.PubMed Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–20.PubMed
49.
go back to reference Geffré A, Concordet D, Braun J-P, Trumel C. Reference Value Advisor: a new freeware set of macroinstructions to calculate reference intervals with Microsoft Excel. Vet Clin Pathol. 2011;40(1):107–12.CrossRefPubMed Geffré A, Concordet D, Braun J-P, Trumel C. Reference Value Advisor: a new freeware set of macroinstructions to calculate reference intervals with Microsoft Excel. Vet Clin Pathol. 2011;40(1):107–12.CrossRefPubMed
50.
go back to reference Molendi-Coste O, Legry V, Leclercq IA. Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract. 2011;2011:364040.CrossRefPubMed Molendi-Coste O, Legry V, Leclercq IA. Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract. 2011;2011:364040.CrossRefPubMed
51.
go back to reference Rise P, Tragni E, Ghezzi S, Agostoni C, Marangoni F, Poli A, et al. Different patterns characterize Omega-6 and Omega-3 long chain polyunsaturated fatty acid levels in blood from Italian infants, children, adults and elderly. Prostaglandins Leukot Essent Fatty Acids. 2013;89:215–20.CrossRefPubMed Rise P, Tragni E, Ghezzi S, Agostoni C, Marangoni F, Poli A, et al. Different patterns characterize Omega-6 and Omega-3 long chain polyunsaturated fatty acid levels in blood from Italian infants, children, adults and elderly. Prostaglandins Leukot Essent Fatty Acids. 2013;89:215–20.CrossRefPubMed
Metadata
Title
Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7–9 year old Zimbabwean children: a cross sectional study
Authors
Grace Mashavave
Patience Kuona
Willard Tinago
Babill Stray-Pedersen
Marshall Munjoma
Cuthbert Musarurwa
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2016
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/s12907-016-0035-7

Other articles of this Issue 1/2016

BMC Clinical Pathology 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.